96 results on '"Cobelli F"'
Search Results
2. Proposal and internal validation of a nomogram for the prediction of local recurrence-free survival after percutaneous ablation for ct1 renal masses
3. Renal tumor heterogeneity in sporadic and inherited renal cancer: a translational multimodal approach
4. PERC-score as a nephrometry scoring system in percutaneous tumour ablation: Comparison with RENAL, mRENAL, PADUA and SPARE in a multi-centre series
5. The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses
6. The risk of von-hippel lindau disease according to individual sporadic cancer in a multidisciplinary program: external validation of the VHL alliance guidelines for genetic referral
7. Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series
8. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
9. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy
10. Prostate cancers detected at multi-parametric MRI targeted versus systematic biopsies: are they equal? Results from a large multi-institutional series
11. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
12. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
13. Are urologists ready for interpretation of multiparametric MRI findings? A prospective multicentric evaluation
14. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel Lindau renal cell carcinoma
15. Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series
16. Imaging intensity after surgery for clear cell renal cell carcinoma
17. Surgical treatment for Von Hippel Lindau renal cell carcinoma: analysis of clinical outcomes from the san raffaele VHL program
18. Assessing the need for systematic biopsies in addition to targeted biopsies according to the volume of the index lesion diagnosed at mpMRI. results from a large, multi-institutional database
19. The detection of a PI-RADS 4–5 lesion at multiparametric MRI before confirmatory biopsy is the strongest predictor of disease progression among men with low-risk prostate cancer included in an active surveillance prospective protocol
20. External validation of the VHL alliance guidelines for VHL genetic testing in patients diagnosed with renal cell carcionoma
21. Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies
22. The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: a multi-institutional study
23. Saturation of the MPMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series
24. Identifying the optimal clinical setting for the use of multiparametric magnetic resonance imaging of the prostate as local staging tool in men candidate to radical prostatectomy. Results from a multi-institutional series
25. Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
26. The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion
27. 16 - Renal tumor heterogeneity in sporadic and inherited renal cancer: a translational multimodal approach
28. P181 - Proposal and internal validation of a nomogram for the prediction of local recurrence-free survival after percutaneous ablation for ct1 renal masses
29. P172 - Perioperative and long-term oncological outcomes after local tumor ablation for complex (PADUA Score =10) cT1a renal tumors: a multicenter analysis
30. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
31. Are men with low risk prostate cancer but high pirads score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
32. Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, multi-institutional cohort
33. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
34. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
35. Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series
36. The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study
37. Can multiparametric MRI improve our ability to predict early biochemical recurrence after radical prostatectomy in contemporary patients? results from a multi-institutional analysis
38. The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy
39. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series
40. Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? development and external validation of a novel T-stage classification based on clinical and MRI findings
41. Should we target all visible areas at mp-MRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series
42. Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? Development and external validation of a novel T-stage classification based on clinical and MRI findings
43. Can multiparametric MRI improve our ability to predict early biochemical recurrence after radical prostatectomy in contemporary patients? Results from a multi-institutional analysis
44. When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series
45. The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy
46. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
47. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series
48. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
49. Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
50. P118 - The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.